Alle verbonden artikelen

Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.

Auteurs : Lucidi V, Bohlok A, Liberale G, Bez M, Germanova D, Bouazza F, Demetter P, Larsimont D, Aftimos P, Smoll NR, Donckier V
Jaar : 2020
Journal : Eur J Surg Oncol
Volume : 46
Pagina's : 229-234

Management of early breast cancer in patients bearing germline BRCA mutations.

Auteurs : Tkint de Roodenbeke D, Pondé N, Buisseret L, Piccart-Gebhart M
Jaar : 2020
Journal : Semin Oncol
Volume : 47
Pagina's : 243-248

Publisher Correction: The adenosine pathway in immuno-oncology.

Auteurs : Allard B, Allard D, Buisseret L, Stagg J
Jaar : 2020
Journal : Nat Rev Clin Oncol
Volume : 17
Pagina's : 650

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Auteurs : Klastersky JA, Dal Lago L, Lalami Y
Jaar : 2020
Journal : Curr Opin Oncol

Immunotherapy in gynecological cancers: where are we?

Auteurs : Polastro L, Closset C, Kerger J
Jaar : 2020
Journal : Curr Opin Oncol
Volume : 32
Pagina's : 459-470

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Auteurs : Coens C, Pe M, Dueck AC, Sloan J, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Devlin N, Dorme L, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, OConnor D, Oliver K, Piault-Louis E, Piccart-Gebhart M, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Bottomley A
Jaar : 2020
Journal : Lancet Oncol
Volume : 21
Pagina's : e83-e96

Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial.

Auteurs : de Angelis C, Ignatiadis M, Piccart-Gebhart M
Jaar : 2020
Journal : Ann Transl Med
Volume : 8
Pagina's : 1338

Effect of the COVID-19 pandemic on cancer treatment and research.

Auteurs : Saini KS, de Las Heras B, de Castro J, Venkitaraman R, Poelman M, Srinivasan G, Saini ML, Verma S, Leone M, Aftimos P, Curigliano G
Jaar : 2020
Journal : Lancet Haematol
Volume : 7
Pagina's : e432-e435

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

Auteurs : de Azambuja E, Ponde N, Procter M, Rastogi P, Cecchini RS, Lambertini M, Ballman K, Aspitia AM, Zardavas D, Roca L, Gelber Rd, Piccart-Gebhart M, Suter T
Jaar : 2020
Journal : Breast Cancer Res Treat
Volume : 179
Pagina's : 161-171

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.

Auteurs : Camera S, Akin Telli T, Woff E, Vandeputte C, Kehagias P, Guiot T, Critchi G, Wissam Y, Bregni G, Trevisi E, Pretta A, Senti C, Leduc S, Gkolfakis P, Hoerner F, Rothé F, Sclafani F, Flamen P, Deleporte A, Hendlisz A
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort.

Auteurs : Cho BC, Daste A, Ravaud A, Salas S, Isambert N, McClay E, Awada A, Borel C, Ojalvo LS, Helwig C, Rolfe PA, Gulley JL, Penel N
Jaar : 2020
Journal : J Immunother Cancer
Volume : 8

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method.

Auteurs : Cuyle PJ, Geboes K, Carton S, Casneuf V, Decaestecker J, De Man M, Demolin G, Deroose CM, De Vleeschouwer C, Flamen P, Hendlisz A, Hoorens A, Janssens J, Karfis I, Lybaert W, Machiels G, Monsaert E, Sinapi I, van Cutsem E, Vandamme T, Borbath I, Verslype C
Jaar : 2020
Journal : Acta Gastroenterol Belg
Volume : 83
Pagina's : 643-653

Important considerations prior to elimination of breast cancer surgery after neoadjuvant systemic therapy: Listening to what our patients want.

Auteurs : Caballero C, Piccart-Gebhart M
Jaar : 2020
Journal : Ann Oncol
Volume : 31
Pagina's : 1083-1084

Lucitanib for the Treatment of HR⁺/HER2^- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.

Auteurs : Hui R, Pearson A, Cortes J, Campbell C, Poirot C, Azim HA Jr, Fumagalli D, Lambertini M, Daly F, Arahmani A, Perez-Garcia J, Aftimos P, Bedard PL, Xuereb L, Scheepers ED, Vicente M, Goulioti T, Loibl S, Loi S, Pierrat MJ, Turner NC, Andre F, Curigliano G
Jaar : 2020
Journal : Clin Cancer Res
Volume : 26
Pagina's : 354-363

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.

Auteurs : Fontana E, Nyamundanda G, Cunningham D, Tu D, Cheang MCU, Jonker DJ, Siu LL, Sclafani F, Eason K, Ragulan C, Bali MA, Hulkki-Wilson S, Loree JM, Waring PM, Giordano M, Lawrence P, Rodrigues DN, Begum R, Shapiro JD, Price TJ, Cremolini C, Starling N, Pietrantonio F, Trusolino L, OCallaghan CJ, Sadanandam A
Jaar : 2020
Journal : JCO Precis Oncol
Volume : 4

MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.

Auteurs : Camera S, Deleporte A, Bregni G, Trevisi E, Pretta A, Telli TA, Polastro L, Gombos A, Kayumba A, Ameye L, Piccart-Gebhart M, Awada A, Sclafani F, Hendlisz A
Jaar : 2020
Journal : Clin Colorectal Cancer
Volume : 19
Pagina's : 311-318.e1

The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥70 years) patients with different cancer tumors.

Auteurs : Quinten C, Kenis C, Decoster L, Debruyne PR, De Groof I, Focan C, Cornelis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, Van den Bulck H, Goeminne JC, Schrijvers D, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lycke M, Flamaing J, Milisen K, Lobelle JP, Wildiers H
Jaar : 2020
Journal : J Geriatr Oncol
Volume : 11
Pagina's : 926-936

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.

Auteurs : Morschhauser F, Machiels JP, Salles G, Rottey S, Rule SAJ, Cunningham D, Peyrade F, Fruchart C, Arkenau HT, Genvresse I, Liu L, Köchert K, Shen K, Kneip C, Peña CE, Grevel J, Zhang J, Cisternas G, Reschke S, Granvil C, Awada A
Jaar : 2020
Journal : Mol Cancer Ther
Volume : 19
Pagina's : 468-478

Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?

Auteurs : Albisinni S, Aoun F, Diamand R, Mjaess G, Esperto F, Martinez Chanza N, Roumeguère T, DE Nunzio C
Jaar : 2020
Journal : Minerva Urol Nefrol
Volume : 72
Pagina's : 663-672

Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.

Auteurs : Lebbé C, Dutriaux C, Lesimple T, Kruit W, Kerger J, Thomas L, Guillot B, Braud F, Garbe C, Grob JJ, Loquai C, Ferraresi V, Robert C, Vasey P, Conry R, Isaacs R, Espinosa E, Schueler A, Massimini G, Dréno B
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12